Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer
Xiaoxiang Sun, Huanyin Tang, Yu Chen, Zhixi Chen, Zhiyi Hu, Zhen Cui, Yaming Tao, Jian Yuan, Yun Fu, Zhigang Zhuang, Qizhi He, Qian Li, Xianghong Xu, Xiaoping Wan, Ying Jiang, Zhiyong Mao
Topics & Concepts
PARP1Cancer researchDeubiquitinating enzymeTriple-negative breast cancerBiologyEstrogen receptorReceptorPoly ADP ribose polymeraseBreast cancerCancerUbiquitinPolymeraseBiochemistryEnzymeGeneticsGenePARP inhibition in cancer therapyDNA Repair MechanismsCell death mechanisms and regulation